Concerns Rising Over CDC’s Handling of Measles Resurgence
The United States is experiencing its most significant measles resurgence in decades, and the situation appears to be worsening. Vaccination rates are on the decline, while illnesses like flu, COVID-19, and RSV continue to resurface. This troubling context has left many public health experts uneasy about the trustworthiness of information coming from the Centers for Disease Control and Prevention (CDC).
Dr. Demetre Daskalakis, who resigned last year as director of the National Center for Immunization and Respiratory Diseases at the CDC, expressed deep concern, stating, “Red flag. Red alert.” His resignation was a response to what he termed political interference within the agency.
Daskalakis and other public health professionals across the nation are particularly alarmed by the CDC’s approach to two recent measles-related deaths in Pennsylvania. Health and Human Services Secretary Robert F. Kennedy Jr. controversially questioned the state’s findings regarding these deaths, leading to the CDC removing them from its website.
“When they raise doubt on the adjudication that a state may have made around a death, that is highly problematic,” warned Daskalakis. “This is dangerous.”
Typically, when such tragic events occur, the state in which they happen determines the cause of death and then informs the CDC. The agency usually relies on the state’s assessment to disseminate information to the public and health officials nationwide.
Kennedy’s public disagreement with Pennsylvania and the CDC’s response could, experts believe, jeopardize the crucial relationship between state and federal health authorities. Daskalakis pointed out that coordination between these entities has already been strained, particularly during the Trump administration.
“What we have been seeing, amplified even more with these measles cases, is a breakdown in the cooperation and trust between states and the federal government,” said Dr. Anne Zink from the Yale School of Public Health. She also voiced concern over the significance of partnerships essential to public health.
Many experts share worries about whether the public, along with state and local health officials, will continue to have faith in federal health data regarding measles and other diseases like flu and COVID-19. Some question if the CDC might be pressured to withhold information to downplay the severity of these issues, especially considering Kennedy’s long-standing skepticism about vaccines.
“We need to have solid, evidence-based national data. There’s a real concern that the same issues could arise with other infectious diseases,” remarked Dr. Georges Benjamin, head of the American Public Health Association. He emphasized that if distrust in data grows, more people could fall ill due to misinformation.
Concerns are also mounting about the effectiveness of the new CDC director, Dr. Erica Schwartz, who recently stepped into her role amidst organizational struggles. There were high hopes that Schwartz would rebuild morale and credibility, but the way her team approached the Pennsylvania measles incidents doesn’t seem to indicate a strong response to political pressure.
“We are seeing a pretty compromised CDC and a director who is, at best, facilitating non-scientific behaviors and at worst, colluding with them,” Daskalakis stated.
Others echoed these sentiments, arguing that Schwartz should prioritize addressing the outbreak rather than getting bogged down with data issues. Dr. Debra Houry, who also resigned as chief medical officer for similar reasons, highlighted the need for Schwartz to advocate for vaccinations, especially with the new school year approaching.
As of now, neither the CDC nor the Department of Health and Human Services has responded to requests for comment.
